ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,742Medicare Part D Prescriptions Filled, Including Refills

Rank: 436 out of 2343

$669K Total Retail Price of All Prescriptions

Rank: 360 out of 2343

531 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 531 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

5% of this provider’s 531 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 10,075 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
LISINOPRIL 670 634 1 3
OMEPRAZOLE 494 449 2 4
LEVOTHYROXINE SODIUM 447 436 3 2
SIMVASTATIN 379 364 4 1
ALENDRONATE SODIUM 349 348 5 28
LOSARTAN POTASSIUM 326 314 6 19
ATENOLOL 300 290 7 12
ATORVASTATIN CALCIUM 255 247 8 10
TRIAMTERENE-HCTZ 245 220 9 57
NIFEDIPINE ER 227 219 10 89
PRAVASTATIN SODIUM 224 218 11 15
METOPROLOL TARTRATE 207 185 12 7
AMLODIPINE BESYLATE 195 182 13 5
ZOLPIDEM TARTRATE 189 170 14 24
FENOFIBRATE 171 156 15 94
WARFARIN SODIUM 167 150 16 8
NEXIUM 160 150 17 33
TRAMADOL HCL 155 130 18 25
FUROSEMIDE 152 152 19 6
DICLOFENAC SODIUM 147 137 20 155
METFORMIN HCL 141 135 21 9
CELEBREX 123 118 22 71
TERAZOSIN HCL 110 107 23 143
CITALOPRAM HBR 107 106 24 17
SYNTHROID 106 101 25 40
NIFEDICAL XL 106 106 25 148
DIGOXIN 102 95 27 35
GABAPENTIN 99 89 28 16
FLUTICASONE PROPIONATE 98 93 29 46
VENLAFAXINE HCL ER 91 73 30 87
PAROXETINE HCL 88 82 31 66
VERAPAMIL ER 82 80 32 95
ZETIA 78 78 33 52
CARVEDILOL 76 73 34 27
MIRTAZAPINE 76 76 34 41
RISPERIDONE 76 76 34 61
ACTOS 74 74 37 125
HYDROCHLOROTHIAZIDE 74 74 37 11
DILTIAZEM 24HR ER 67 64 39 76
POTASSIUM CHLORIDE 65 64 40 18
GLYBURIDE 63 63 R 41 62
NORTRIPTYLINE HCL 62 46 42 239
ACTONEL 61 61 43 182
PREDNISONE 60 60 44 37
RANITIDINE HCL 60 59 44 43
DOXAZOSIN MESYLATE 58 44 46 98
TRIAMCINOLONE ACETONIDE 58 58 46 137
CLOPIDOGREL 57 57 48 26
PANTOPRAZOLE SODIUM 57 57 48 22
JANUVIA 56 56 50 50
FENTANYL 55 53 S2 51 69
TRAZODONE HCL 52 40 52 53
IRBESARTAN 52 47 52 270
HYDROCODONE-ACETAMINOPHEN 52 51 S3 52 13
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 15, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.